5. Conclusions
CERVICAL CANCER
In conclusion, we reported the early safety and efficacy results of combining chemo-CIRT and durvalumab for locally advanced cervical cancer. The long-term follow-up of this dataset and the immune response in these patient samples will be reported in future articles.